Article info

Original research
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity

Authors

  • Congcong Zhang Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, GermanyGerman Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, GermanyGerman Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute, Goethe University, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Jasmin Röder Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, GermanyFrankfurt Cancer Institute, Goethe University, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Anne Scherer Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Malena Bodden Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Jordi Pfeifer Serrahima Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Anita Bhatti Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Anja Waldmann Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Nina Müller Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Pranav Oberoi Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, GermanyGerman Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, GermanyGerman Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Winfried S Wels Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, GermanyGerman Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, GermanyGerman Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute, Goethe University, Frankfurt, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Winfried S Wels; wels{at}gsh.uni-frankfurt.de
View Full Text

Citation

Zhang C, Röder J, Scherer A, et al
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity

Publication history

  • Accepted September 16, 2021
  • First published October 1, 2021.
Online issue publication 
October 01, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.